The first Global Women’s (GLOW) Research Conference was held in Liverpool this week. The conference brought together 150 researchers and clinicians from across the globe to discuss women’s health in both low and high resource countries. Keynote speakers included France Donnay from the Bill & Melinda Gates Foundation, and Beverly Winikoff from Gynuity Health Projects.
BU was well represented with poster presentations from Vanora Hundley, Professor of Midwifery, and Emma Pitchforth, Visiting Fellow.
Vanora’s presentation examined the Use of oral misoprostol to prevent postpartum haemorrhage in home birth settings in low resource countries; a topic that has been the subject of considerable controversy in recent weeks. Emma’s presentation looked at Evidence response mechanisms in reproductive, maternal, newborn and child health in Asia and the Pacific.
One of the unique features of this conference was the mix of presentations. Presenters came from a variety of disciplines and alongside the well known international speakers were oral presentations from undergraduate students and early career researchers. This was a great opportunity to share experiences and build collaborations, and I would recommend that both staff and students look out for next year’s call for abstracts.
BU well represented at Global Women’s (GLOW) Research Conference
International survey post-Millennium Development Goals










New BU Physiology paper
Gender and street names
Help Shape the Future of Research at BU: Postgraduate Research Experience Survey 2026 Now Open
3C Event: Research Culture, Community & Cherry Blossom – Tuesday 14 April
REMINDER: 3MT® Competition – Deadline 9am Monday 20 April
New academic paper on Nepal
ECR Funding Open Call: Research Culture & Community Grant – Apply now
ECR Funding Open Call: Research Culture & Community Grant – Application Deadline Friday 12 December
MSCA Postdoctoral Fellowships 2025 Call
ERC Advanced Grant 2025 Webinar
Update on UKRO services
European research project exploring use of ‘virtual twins’ to better manage metabolic associated fatty liver disease